Stayble Therapeutics AB publ announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue - ar was SEK 0 compared to SEK 71,000 a year ago. Operating loss was SEK 2.383 million compared to SEK 6.324 million a year ago. Net loss was SEK 2.456 million compared to SEK 6.334 million a year ago. For the half year, total revenue - ar was SEK 0 compared to SEK 71,000 a year ago. Operating loss was SEK 4.507 million compared to SEK 11.367 million a year ago. Net loss was SEK 4.515 million compared to SEK 11.738 million a year ago.